Monterra Stucco Rebrands from ICE Stucco Repair to Reflect the Premium Homes It Serves

HOUSTON, March 05, 2026 (GLOBE NEWSWIRE) — ICE Stucco Repair, a trusted stucco remediation company serving Houston-area homeowners, announced today that it has officially rebranded as Monterra Stucco. While the name and visual identity are new, the leadership, team, processes, and workmanship standards remain exactly the same. “Nothing about our ownership, our team, or our […]

Delinea Completes StrongDM Acquisition to Secure AI Agents with Continuous Identity Authorization

SAN FRANCISCO, March 05, 2026 (GLOBE NEWSWIRE) — Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, has completed its acquisition of StrongDM, the universal access management company purpose-built for modern engineering, DevOps, and AI-driven environments. As enterprises scale agentic AI and automation, privileged access is increasingly required by

Manifest Names Betsy Ross Chief Client Officer

CHICAGO, March 05, 2026 (GLOBE NEWSWIRE) — Manifest, the independent full-service agency, today announced Betsy Ross has joined the company as Chief Client Officer. Ross' hire reinforces Manifest's commitment to deepening client partnerships and scaling its fully integrated model built to win the middle journey and accelerate growth. Ross joins Manifest from BarkleyOKRP at a

Kestrel Therapeutics Announces IND Clearance by U.S. FDA of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, Enabling Initiation of Phase 1 Trial

WATERTOWN, Mass., March 05, 2026 (GLOBE NEWSWIRE) — Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical stage biotechnology company developing next-generation small-molecule inhibitors targeting mutant KRAS, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for KST-6051, an investigational, oral, small-molecule inhibitor designed to target

Starton Therapeutics Files Patent Applications for the Use of CAR-T Cell Therapies in Combination with its Proprietary, Continuous Low-Dose Immunomodulatory Therapy, STAR-LLD, a formulation of Lenalidomide, for the Treatment of Blood Cancer

The potential of STAR-LLD to improve lenalidomide's therapeutic index suggests an opportunity for use in combination with CAR-T cell therapies. As described in the patent application, STAR-LLD's improved therapeutic index appears to support sustained immunologic activity and T cell fitness, without the systemic toxicity associated with conventional oral IMiDs and degraders. PARAMUS, N.J., March 05,

New Survey Reveals Over Half of Americans Delayed Healthcare in Past Year, Citing Cost and Schedule Conflicts as Primary Barriers

MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) — A new survey commissioned by Nice Healthcare reveals a clear and consequential breakdown in the American healthcare continuum: 52% of U.S. adults have delayed or skipped necessary care in the past 12 months. The findings, gathered from over 1,000 adults, paint a troubling picture of a system where

Patriot Mobile Sponsors Texas Army National Guard Graduation

Grapevine, TX, March 05, 2026 (GLOBE NEWSWIRE) — Patriot Mobile, America's only Christian conservative wireless provider, is proud to announce their sponsorship of the Texas Army National Guard Officer Candidate School (OCS) Graduation on April 11, 2026. This OCS program has produced exceptional leaders, including distinguished graduates like Major Richard “Dick” Winters and Senator Robert

Guident and JTA Announce 5th Annual Autonomous Vehicle Conference

BOCA RATON, Florida, March 05, 2026 (GLOBE NEWSWIRE) — Guident Corp. (“Guident”), in partnership with the Jacksonville Transportation Authority (“JTA”), today announced the 5th Annual Autonomous Vehicle Conference (formerly National Autonomous Vehicle Day), will take place May 29, 2026, at the Boca Raton Innovation Campus (BRiC). Now in its fifth year, the Autonomous Vehicle Conference

Arax Adds Pinnacle Peak Private Client Group to Ashton Thomas

NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) — Arax Investment Partners today announced that Pinnacle Peak Private Client Group (“Pinnacle Peak”) has joined Ashton Thomas Private Wealth (“Ashton Thomas”). This deal continues Ashton Thomas' rapid pace of growth, adding another team of experienced advisors, enhancing the firm's footprint in the Southwest and bringing a wider

Collegium to Present New Real-World Data at PainConnect 2026

(NASDAQ:COLL), STOUGHTON, Mass., March 05, 2026 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present two posters featuring real-world data from its portfolio of differentiated pain medications at PainConnect 2026, the American Academy of Pain Medicine (AAPM)'s Annual Meeting, taking place in Salt Lake City, Utah from March 5-8, 2026. The

Scroll to Top